Literature DB >> 3316922

Spontaneous bacterial peritonitis. A review of pathogenesis, diagnosis, and treatment.

C M Wilcox1, W E Dismukes.   

Abstract

Spontaneous bacterial peritonitis (SBP) is an increasingly recognized complication of cirrhosis with ascites. However, the presence of ascites from any cause appears to be a risk factor for this infection. The etiology of SBP is multifactorial, including derangements in the reticuloendothelial system, abnormalities of both the serum and ascitic fluid humoral immune systems, and systemic bacteremia. Gram-negative enteric pathogens are the etiologic agents in 70% of the cases; anaerobes are an uncommon cause. Fever and abdominal pain are the most common presenting symptoms. However, asymptomatic patients are being increasingly recognized. When SBP is suspected, paracentesis is indicated. An absolute polymorphonuclear leukocyte count greater than 500/mm3 is highly suggestive of SBP. Ascitic fluid lactate and pH may offer additional diagnostic assistance when the PMN count is ambiguous. Appropriate antibiotic therapy should be initially based on the centrifuged Gram stain of ascites as well as the patient's renal function. Mortality is substantial and appears to be related to the severity of the underlying liver disease.

Entities:  

Mesh:

Year:  1987        PMID: 3316922

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  19 in total

Review 1.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

Review 2.  Spontaneous bacterial peritonitis caused by Listeria monocytogenes: two case reports and literature review.

Authors:  A Polanco; C Giner; R Cantón; A León; M Garcia Gonzalez; F Baquero; M Meseguer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

3.  Distribution of ciprofloxacin in ascitic fluid following administration of a single oral dose of 750 milligrams.

Authors:  M Dan; T Zuabi; C Quassem; H H Rotmensch
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

4.  Penetration of cefoperazone into ascites.

Authors:  A Van Gossum; M Quenon; M Van Gossum; A Herchuelz; J P Thys
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Infectious complications of liver disease.

Authors:  P D King
Journal:  J Gen Intern Med       Date:  1993-06       Impact factor: 5.128

Review 6.  Primary and secondary peritonitis: an update.

Authors:  M Laroche; G Harding
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

Review 7.  Listeria monocytogenes peritonitis in cirrhotic patients. Value of ascitic fluid gram stain and a review of literature.

Authors:  M H Nguyen; V L Yu
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

8.  Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.

Authors:  J Gómez-Jiménez; E Ribera; I Gasser; M A Artaza; O Del Valle; A Pahissa; J M Martínez-Vázquez
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 9.  [Spontaneous bacterial peritonitis].

Authors:  J Zundler; J C Bode
Journal:  Med Klin (Munich)       Date:  1998-10-15

10.  Prevalence and prognostic significance of bacterascites in cirrhosis with ascites.

Authors:  C M Chu; K Y Chang; Y F Liaw
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.